Gail Naughton - Aug 18, 2022 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Director
Signature
/s/ Gail K. Naughton, Ph.D
Stock symbol
TXMD
Transactions as of
Aug 18, 2022
Transactions value $
$0
Form type
4
Date filed
8/22/2022, 06:00 AM
Previous filing
Aug 8, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise +1.98K +102.37% 3.92K Aug 18, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -1.98K -100% $0.00* 0 Aug 18, 2022 Common Stock 1.98K $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022.
F2 Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F3 The RSUs vested on July 1, 2022.